skip to content
Dovepress - Open Access to Scientific and Medical Research
View our mobile site

8852

Role of bendamustine in the treatment of chronic lymphocytic leukemia

Review

(3260) Views  (1234) Full article downloads

Authors: Saad Jamshed, Bruce D Cheson

Published Date March 2009 Volume 2009:2 Pages 43 - 49
DOI: http://dx.doi.org/10.2147/OTT.S3913

Saad Jamshed, Bruce D Cheson

Georgetown University Hospital, Lombardi Comprehensive Cancer Center, Washington, DC, USA

Abstract: Major advances in the management of patients with chronic lymphocytic leukemia (CLL) include an enhanced ability to make an accurate diagnosis and define clinically meaningful prognostic groups, while improving outcome through more effective therapeutic regimens and supportive care. Nevertheless, CLL remains an incurable disorder and new, active agents are needed. Bendamustine, a unique cytotoxic agent with structural similarities to both alkylating agents and antimetabolites, was recently approved by the US Food and Drug Administration for treatment of CLL and rituximab-refractory indolent non-Hodgkin’s lymphoma. In a randomized trial, bendamustine was superior to chlorambucil, with comparable toxicity. Combinations with other active agents including rituximab and lenalidomide are in development. Nevertheless, numerous questions concerning the ideal use of this agent remain to be addressed, including the optimal dose and schedule and mechanisms of resistance. The availability of bendamustine provides another effective treatment option for patients with lymphoproliferative disorders. Rational development of combination regimens will improve the outlook for patients with CLL.

Keywords: bendamustine, chemotherapy, chronic lymphocytic leukemia








Readers of this article also read:

Role of aliskiren in cardio-renal protection and use in hypertensives with multiple risk factors
Multiple roles and therapeutic implications of Akt signaling in cancer
Lenalidomide in multiple myeloma: an evidence-based review of its role in therapy
Bendamustine in the treatment of non-Hodgkin’s lymphomas
Health literacy and health seeking behavior among older men in a middle-income nation
Functional mobility and balance in community-dwelling elderly submitted to multisensory versus strength exercises
Retinal nerve fiber layer evaluation in multiple sclerosis with spectral domain optical coherence tomography
Zinc oxide nanoparticles as selective killers of proliferating cells
Differences in maintenance of mean blood glucose (BG) and their association with response to “recognizing hunger”
Cumulative clinical experience from over a decade of use of levofloxacin in community-acquired pneumonia: critical appraisal and role in therapy